Sex differences in carcinoid syndrome: A gap to be closed-Reference-Cited by-同舟云学术

Sex differences in carcinoid syndrome: A gap to be closed

Published:2022-03-16 Issue:3 Volume:23 Page:659-669
ISSN:1389-9155
Container-title:Reviews in Endocrine and Metabolic Disorders
language:en
Short-container-title:Rev Endocr Metab Disord

Author:

Ruggeri Rosaria M.,Altieri Barbara,Grossrubatcher Erika,Minotta Roberto,Tarsitano Maria Grazia,Zamponi Virginia,MIsidori Andrea,Faggiano Antongiulio,Colao Anna Maria,

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s11154-022-09719-8.pdf

Reference110 articles.

1. Baggio G, Corsini A, Floreani A, Giannini S, Zagonel V. Gender medicine: a task for the third millennium. Clin Chem Lab Med. 2013;51(4):713–27.

2. Oertelt-Prigione S. The influence of sex and gender on the immune response. Autoimmun Rev. 2012;11(6–7):A479–85.

3. Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet. 2012;3:268.

4. Mogl MT, Dobrindt EM, Buschermöhle J, Bures C, Pratschke J, Amthauer H, et al. Influence of gender on therapy and outcome of neuroendocrine tumors of gastroenteropancreatic origin: a single-center analysis. Visc Med. 2020;36(1):20–7.

5. Muscogiuri G, Altieri B, Albertelli M, Dotto A, Modica R, Barrea L, et al. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective. Endocrine. 2020;69(2):441–50.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex Differences in the Survival of Patients with Neuroendocrine Neoplasms: A Comparative Study of Two National Databases;Cancers;2024-06-28

2. Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors;Reviews in Endocrine and Metabolic Disorders;2023-12-05

3. Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study;Journal of Endocrinological Investigation;2023-10-14

4. Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors;Expert Review of Anticancer Therapy;2023-05-15

5. The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms;Cancers;2022-12-24